105 related articles for article (PubMed ID: 9502605)
1. Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease.
Karunaweera ND; Carter R; Grau GE; Mendis KN
Am J Trop Med Hyg; 1998 Feb; 58(2):204-10. PubMed ID: 9502605
[TBL] [Abstract][Full Text] [Related]
2. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
[TBL] [Abstract][Full Text] [Related]
3. Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka.
Gamage-Mendis AC; Rajakaruna J; Carter R; Mendis KN
Parasite Immunol; 1992 Jul; 14(4):385-96. PubMed ID: 1437231
[TBL] [Abstract][Full Text] [Related]
4. Immune responses against sexual stages of Plasmodium vivax during human malarial infections in Sri Lanka.
Carter R; Mendis KN
Parassitologia; 1991 Apr; 33(1):67-70. PubMed ID: 1688139
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity.
Carter R; David P; Mendis K
Parassitologia; 1993 Jul; 35 Suppl():17-8. PubMed ID: 8233604
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting.
Dewasurendra RL; Dias JN; Sepulveda N; Gunawardena GS; Chandrasekharan N; Drakeley C; Karunaweera ND
BMC Infect Dis; 2017 Jan; 17(1):49. PubMed ID: 28068925
[TBL] [Abstract][Full Text] [Related]
7. Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka.
Gamage-Mendis AC; Rajakaruna J; Carter R; Mendis KN
Am J Trop Med Hyg; 1991 Oct; 45(4):479-87. PubMed ID: 1951856
[TBL] [Abstract][Full Text] [Related]
8. Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka.
Wickramarachchi T; Premaratne PH; Perera KL; Bandara S; Kocken CH; Thomas AW; Handunnetti SM; Udagama-Randeniya PV
Infect Immun; 2006 Jan; 74(1):798-801. PubMed ID: 16369044
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the lymphocyte cell population during malaria caused by Plasmodium vivax and its correlation with parasitaemia and thrombocytopaenia.
Ourives SS; Borges QI; Dos Santos DSA; Melo ECM; de Souza RM; Damazo AS
Malar J; 2018 Aug; 17(1):303. PubMed ID: 30126413
[TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients.
Karunaweera ND; Carter R; Grau GE; Kwiatkowski D; Del Giudice G; Mendis KN
Clin Exp Immunol; 1992 Jun; 88(3):499-505. PubMed ID: 1351432
[TBL] [Abstract][Full Text] [Related]
11. Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey.
Zeyrek FY; Kurcer MA; Zeyrek D; Simsek Z
Parasite Immunol; 2006 May; 28(5):201-7. PubMed ID: 16629705
[TBL] [Abstract][Full Text] [Related]
12. Role of IL-1β, IL-6 and TNF-α cytokines and TNF-α promoter variability in Plasmodium vivax infection during pregnancy in endemic population of Jharkhand, India.
Singh KP; Shakeel S; Naskar N; Bharti A; Kaul A; Anwar S; Kumari S; Kumar A; Singh JK; Kumari N; Gupta BK; Manna P; Roy V; Lata S; Singh OP; Sinha MP; Sharma AK; Sohail M
Mol Immunol; 2018 May; 97():82-93. PubMed ID: 29602073
[TBL] [Abstract][Full Text] [Related]
13. Human T cell proliferative responses to Plasmodium vivax antigens: evidence of immunosuppression following prolonged exposure to endemic malaria.
Goonewardene R; Carter R; Gamage CP; Del Giudice G; David PH; Howie S; Mendis KN
Eur J Immunol; 1990 Jun; 20(6):1387-91. PubMed ID: 2196178
[TBL] [Abstract][Full Text] [Related]
14. Human cytokine responses to meso-endemic malaria on the Pacific Coast of Colombia.
Praba-Egge AD; Montenegro S; Arevalo-Herrera M; Hopper T; Herrera S; James MA
Ann Trop Med Parasitol; 2003 Jun; 97(4):327-37. PubMed ID: 12831518
[TBL] [Abstract][Full Text] [Related]
15. Clinical diagnosis of uncomplicated malaria in Sri Lanka.
van der Hoek W; Premasiri DA; Wickremasinghe AR
Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):242-5. PubMed ID: 9886105
[TBL] [Abstract][Full Text] [Related]
16. A malaria parasite toxin associated with Plasmodium vivax paroxysms.
Wijesekera SK; Carter R; Rathnayaka L; Mendis KN
Clin Exp Immunol; 1996 May; 104(2):221-7. PubMed ID: 8625512
[TBL] [Abstract][Full Text] [Related]
17. Genotyping of Plasmodium vivax infections in Sri Lanka using Pvmsp-3alpha and Pvcs genes as markers: a preliminary report.
Aresha M; Sanath M; Deepika F; Renu W; Anura B; Chanditha H; Wimaladharma A; Rajitha W
Trop Biomed; 2008 Aug; 25(2):100-6. PubMed ID: 18948880
[TBL] [Abstract][Full Text] [Related]
18. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria.
Hemmer CJ; Holst FG; Kern P; Chiwakata CB; Dietrich M; Reisinger EC
Trop Med Int Health; 2006 Jun; 11(6):817-23. PubMed ID: 16772003
[TBL] [Abstract][Full Text] [Related]
19. Genetic complexity of Plasmodium vivax infections in Sri Lanka, as reflected at the merozoite-surface-protein-3alpha locus.
Wickramarachchi T; Premaratne PH; Dias S; Handunnetti SM; Udagama-Randeniya PV
Ann Trop Med Parasitol; 2010 Mar; 104(2):95-108. PubMed ID: 20406577
[TBL] [Abstract][Full Text] [Related]
20. Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
Schousboe ML; Rajakaruna RS; Salanti A; Hapuarachchi HC; Galappaththy GN; Bygbjerg IC; Amerasinghe PH; Konradsen F; Alifrangis M
Malar J; 2007 Mar; 6():28. PubMed ID: 17349045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
